speb/financial-data huggingface dataset:
Financial ratios for QCX.V — annual report dated 2022-12-31
Total revenue: 0
Operating income: -119728.67647058822
Net income: -115456.61764705881
Capital expenditures: 35413.23529411764
Operating cash flow: 25977.20588235294
Net tangible assets: 2855802.9411764704
Owner earnings: -150869.85294117645
Return on net tangible assets (%): -5.282922388161153
Buffett classification: The Gruesome
Stock price: 0.14705882352941177
Shares outstanding: 22616825
Book value: 2855802.9411764704
P/B ratio: 1.1646474721748186
Market cap (USD): 3326003.6764705884
Debt to equity: 0
Current ratio: 0.8312491685512837
Quick ratio: 0.8312491685512837
Free cash flow (dilution-adjusted): -9436.029411764704
Buyback yield (%): 0
Retained earnings: -11476513.970588235
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -4.19246982150894
Rule of 40 score: 0
Financial ratios for QCX.V — annual report dated 2023-12-31
Total revenue: 0
Operating income: -124127.27272727272
Net income: -98791.66666666666
Capital expenditures: 149758.3333333333
Operating cash flow: -144956.81818181818
Net tangible assets: 3164409.090909091
Owner earnings: -248549.99999999997
Return on net tangible assets (%): -7.854547021560824
Buffett classification: The Gruesome
Stock price: 0.15151515151515152
Shares outstanding: 22616825
Book value: 3164409.0909090904
P/B ratio: 1.0829167684138454
Market cap (USD): 3426791.666666667
Debt to equity: 0
Current ratio: 1.612883761837557
Quick ratio: 1.612883761837557
Free cash flow (dilution-adjusted): -294715.1515151515
Buyback yield (%): 0
Retained earnings: -11923078.787878787
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -3.922605110820633
Rule of 40 score: 0
Financial ratios for QCX.V — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 0.07407407407407407
Shares outstanding: 22616825
Market cap (USD): 1675320.3703703703
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for QCX.V — quarterly report dated 2024-12-31
Capital expenditures: 48697.9020979021
Buffett classification: The Gruesome
Stock price: 0.06993006993006994
Shares outstanding: 22616825
Market cap (USD): 1581596.153846154
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for QCX.V — annual report dated 2024-12-31
Total revenue: 0
Operating income: -127357.34265734267
Net income: -124725.17482517484
Capital expenditures: 49490.909090909096
Operating cash flow: -104922.37762237762
Net tangible assets: 2796267.832167832
Owner earnings: -174216.08391608394
Return on net tangible assets (%): -6.230307480275283
Buffett classification: The Gruesome
Stock price: 0.06993006993006994
Shares outstanding: 22616825
Book value: 2796267.832167832
P/B ratio: 0.5656096800355519
Market cap (USD): 1581596.153846154
Debt to equity: 0
Current ratio: 0.2158770586804413
Quick ratio: 0.2158770586804413
Free cash flow (dilution-adjusted): -154413.2867132867
Buyback yield (%): 0
Retained earnings: -11130644.055944057
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -4.554547357454229
Rule of 40 score: 0
Financial ratios for QCX.V — quarterly report dated 2025-03-31
Total revenue: 0
Operating income: -30792.307692307695
Net income: -22932.167832167834
Capital expenditures: 594.4055944055945
Operating cash flow: -31774.125874125875
Net tangible assets: 2773335.6643356644
Owner earnings: -23526.573426573428
Return on net tangible assets (%): -0.8483132326576515
Buffett classification: The Gruesome
Stock price: 0.13986013986013987
Shares outstanding: 22616825
Book value: 2773335.6643356644
P/B ratio: 1.1405731907500751
Market cap (USD): 3163192.307692308
Debt to equity: 0
Current ratio: 0.19166941741057664
Quick ratio: 0.19166941741057664
Free cash flow (dilution-adjusted): -69295.1048951049
Buyback yield (%): 0
Retained earnings: -11153576.223776225
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -1.1102986230007539
Rule of 40 score: 0
Financial ratios for QCX.V — quarterly report dated 2025-06-30
Total revenue: 0
Operating income: -39308.02919708029
Net income: -31264.233576642335
Capital expenditures: 61861.313868613135
Operating cash flow: 43139.416058394156
Net tangible assets: 2863531.3868613136
Owner earnings: -93125.54744525548
Return on net tangible assets (%): -3.252122462234626
Buffett classification: The Gruesome
Stock price: 0.0875912408759124
Shares outstanding: 22616825
Book value: 2863531.3868613136
P/B ratio: 0.691815628602119
Market cap (USD): 1981035.7664233574
Debt to equity: 0
Current ratio: 0.09592006274445052
Quick ratio: 0.09592006274445052
Free cash flow (dilution-adjusted): -18721.897810218976
Buyback yield (%): 0
Retained earnings: -11673318.248175181
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -1.3727116586686134
Rule of 40 score: 0
Financial ratios for QCX.V — quarterly report dated 2025-09-30
Total revenue: 0
Operating income: -189569.06474820146
Net income: -189569.06474820146
Capital expenditures: 0
Operating cash flow: -101207.19424460432
Net tangible assets: 3291463.309352518
Owner earnings: -189569.06474820146
Return on net tangible assets (%): -5.759416008361723
Buffett classification: The Gruesome
Stock price: 0.1798561151079137
Shares outstanding: 22616825
Book value: 3291463.309352518
P/B ratio: 1.2358558787567753
Market cap (USD): 4067774.28057554
Debt to equity: 0
Current ratio: 3.281497447532615
Quick ratio: 3.281497447532615
Free cash flow (dilution-adjusted): -101207.19424460432
Buyback yield (%): 0
Retained earnings: -11694925.899280576
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -5.759416008361723
Rule of 40 score: 0
Financial ratios for QCX.V — quarterly report dated 2025-12-31
Total revenue: 0
Operating income: -36087.59124087591
Net income: -48575.18248175182
Capital expenditures: 35018.24817518248
Operating cash flow: -43562.04379562043
Net tangible assets: 5040938.686131386
Owner earnings: -83593.4306569343
Return on net tangible assets (%): -1.6582909624930822
Buffett classification: The Gruesome
Stock price: 0.18248175182481752
Shares outstanding: 22616825
Book value: 5040938.686131386
P/B ratio: 0.8187280392975125
Market cap (USD): 4127157.8467153283
Debt to equity: 0
Current ratio: 2.110059802903108
Quick ratio: 2.110059802903108
Free cash flow (dilution-adjusted): -78580.29197080291
Buyback yield (%): 0
Retained earnings: -11914229.927007299
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -0.7158903031326282
Rule of 40 score: 0
Financial ratios for QCX.V — annual report dated 2025-12-31
Total revenue: 0
Operating income: -299872.9927007299
Net income: -296112.40875912405
Capital expenditures: 97499.99999999999
Operating cash flow: -136272.99270072993
Net tangible assets: 5040938.686131386
Owner earnings: -393612.40875912405
Return on net tangible assets (%): -7.808315737742044
Buffett classification: The Gruesome
Stock price: 0.18248175182481752
Shares outstanding: 22616825
Book value: 5040938.686131386
P/B ratio: 0.8187280392975125
Market cap (USD): 4127157.8467153283
Debt to equity: 0
Current ratio: 2.110059802903108
Quick ratio: 2.110059802903108
Free cash flow (dilution-adjusted): -424869.3430656934
Buyback yield (%): 0
Retained earnings: -11914229.927007299
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -5.948753027402208
Rule of 40 score: 0
Financial ratios for RDZN — annual report dated 2022-03-31
Total revenue: 9988728
Gross profit: 5182710
Operating income: -6238896
Net income: -9741832
Capital expenditures: 1080513
Operating cash flow: -4066053
Depreciation & amortization: 1370143
Net tangible assets: -42355651
Owner earnings: -9452202
Buffett classification: The Gruesome
Stock price: 9.99
Shares outstanding: 84562603
Book value: -36952045
Market cap (USD): 844780403.97
Debt to equity: -0.641994049314456
Current ratio: 0.8425345350158194
Quick ratio: 0.832875071013892
Interest coverage ratio: -138.86122548910504
COGS to revenue (%): 48.11441456810117
R&D to revenue (%): 13.086841487724962
SG&A to revenue (%): 87.54121645919281
Free cash flow (dilution-adjusted): -5147348
Buyback yield (%): 0
Retained earnings: -37057245
Inventory turnover: 87.05292711201275
Receivables turnover: 4.8284581770370085
Capitalized R&D asset: 1307209
ROCI (R&D-adjusted, %): -46.81078460298117
FCF margin (%): -51.53156638162537
Rule of 40 score: -51.53156638162537
Financial ratios for RDZN — annual report dated 2023-03-31
Total revenue: 13560498
Gross profit: 8146812
Operating income: -11532144
Net income: -14024268
Capital expenditures: 841359
Operating cash flow: -7546704
Depreciation & amortization: 1624208
Net tangible assets: -54310802
Owner earnings: -13241419
Buffett classification: The Gruesome
Stock price: 10.45
Shares outstanding: 84562603
Book value: -51082898
Market cap (USD): 883679201.3499999
Debt to equity: -0.1752171734657654
Current ratio: 0.3217337744878682
Quick ratio: 0.3181432545347571
Interest coverage ratio: -14.86056985424401
COGS to revenue (%): 39.92247187382056
R&D to revenue (%): 19.691998037240225
SG&A to revenue (%): 113.45022137092606
Free cash flow (dilution-adjusted): -8388749
Buyback yield (%): 0
Retained earnings: -51448299
Inventory turnover: 90.38325792610648
Receivables turnover: 5.357138539759293
Capitalized R&D asset: 3546163.0300000003
ROCI (R&D-adjusted, %): -498.07170086885935
Rosenberg metric: 2.267504278198819
FCF margin (%): -61.861658767989205
Revenue growth (%): 35.75800642484208
Rule of 40 score: -26.103652343147125
Financial ratios for RDZN — annual report dated 2024-03-31
Total revenue: 46724287
Gross profit: 28591530
Operating income: -77658837
Net income: -99669335
Capital expenditures: 455924
Operating cash flow: -19218165
Depreciation & amortization: 2185858
Net tangible assets: -15124993
Owner earnings: -97939401
Buffett classification: The Gruesome
Stock price: 6.5
Shares outstanding: 84562603
Book value: -10499866
Market cap (USD): 549656919.5
Debt to equity: -1.9127759344738304
Current ratio: 0.759187638625706
Quick ratio: 0.7581112593021202
Interest coverage ratio: -33.89553376226418
COGS to revenue (%): 38.807990799303155
R&D to revenue (%): 10.645033491896836
SG&A to revenue (%): 212.07534531238542
Free cash flow (dilution-adjusted): -75977224
Buyback yield (%): 0
Retained earnings: -151008419
Inventory turnover: 256.5944075735492
Receivables turnover: 8.52579610436792
Capitalized R&D asset: 7194318.08
Rosenberg metric: 7.656242873079874
FCF margin (%): -162.60756210148267
Revenue growth (%): 244.56173364724512
Rule of 40 score: 81.95417154576245
Financial ratios for RDZN — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 1.19
Shares outstanding: 84562603
Market cap (USD): 100629497.57
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for RDZN — quarterly report dated 2024-12-31
Total revenue: 12086286
Gross profit: 7810499
Operating income: -3168813
Net income: -2517690
Capital expenditures: 89861
Operating cash flow: -3180079
Depreciation & amortization: 299949
Net tangible assets: -33060371
Owner earnings: -2307602
Buffett classification: The Gruesome
Stock price: 2.18
Shares outstanding: 84562603
Book value: -30474403
Market cap (USD): 184346474.54000002
Debt to equity: -0.7716996785794294
Current ratio: 0.4236067135868943
Quick ratio: 0.4217407165654104
Interest coverage ratio: -2.919687725162762
COGS to revenue (%): 35.37717872967759
R&D to revenue (%): 2.0654401194874916
SG&A to revenue (%): 86.29390368554905
Free cash flow (dilution-adjusted): -3388660
Buyback yield (%): 0
Retained earnings: -223731995
Inventory turnover: 37.341813386431916
Receivables turnover: 1.9287093384440954
Capitalized R&D asset: 249635
FCF margin (%): -28.037231619374225
Rule of 40 score: -28.037231619374225
Financial ratios for RDZN — annual report dated 2025-03-31
Total revenue: 44296098
Gross profit: 25462880
Operating income: -60812942
Net income: -72870432
Capital expenditures: 424910
Operating cash flow: -18142198
Depreciation & amortization: 2020610
Net tangible assets: -28378703
Owner earnings: -71274732
Buffett classification: The Gruesome
Stock price: 1.04
Shares outstanding: 84562603
Book value: -25690780
Market cap (USD): 87945107.12
Debt to equity: -0.9286282861010837
Current ratio: 0.4734302639360633
Quick ratio: 0.46987298074319583
Interest coverage ratio: -18.72417068498946
COGS to revenue (%): 42.51665236969631
R&D to revenue (%): 8.533381427863015
SG&A to revenue (%): 181.67572457510818
Free cash flow (dilution-adjusted): -65778924
Buyback yield (%): 0
Retained earnings: -223826442
Inventory turnover: 92.98747376996569
Receivables turnover: 5.01806469840757
Capitalized R&D asset: 7993621.61
Rosenberg metric: -0.629024073266884
FCF margin (%): -148.49823566852322
Revenue growth (%): -5.1968454863741425
Rule of 40 score: -153.69508115489737
Financial ratios for RDZN — quarterly report dated 2025-03-31
Total revenue: 11404197
Gross profit: 7491826
Operating income: -3708415
Net income: -135678
Capital expenditures: 374492
Operating cash flow: -3710954
Depreciation & amortization: 1046940
Net tangible assets: -28378703
Owner earnings: 536770
Buffett classification: The Gruesome
Stock price: 1.04
Shares outstanding: 84562603
Book value: -25690780
Market cap (USD): 87945107.12
Debt to equity: -0.9286282861010837
Current ratio: 0.4734302639360633
Quick ratio: 0.46987298074319583
Interest coverage ratio: -5.193967660385022
COGS to revenue (%): 34.30641368261176
R&D to revenue (%): 2.1411152402926747
SG&A to revenue (%): 86.89015105579114
Free cash flow (dilution-adjusted): -4161843
Buyback yield (%): 0
Retained earnings: -223826442
Inventory turnover: 19.317011874490827
Receivables turnover: 1.2919196264055925
Capitalized R&D asset: 411432.45
Rosenberg metric: -1.2765557714262823
FCF margin (%): -36.49395919765329
Revenue growth (%): -5.643495445995569
Rule of 40 score: -42.13745464364886
Financial ratios for RDZN — quarterly report dated 2025-06-30
Total revenue: 10865545
Gross profit: 6396092
Operating income: -2520349
Net income: -4005770
Capital expenditures: 274056
Operating cash flow: -2921507
Depreciation & amortization: 125000
Net tangible assets: -31648540
Owner earnings: -4154826
Buffett classification: The Gruesome
Stock price: 0.98
Shares outstanding: 84562603
Book value: -28793751
Market cap (USD): 82871350.94
Debt to equity: -0.8522890956443987
Current ratio: 0.44696751722533884
Quick ratio: 0.44533102980739403
Interest coverage ratio: -2.677465343841992
COGS to revenue (%): 41.134181488365286
R&D to revenue (%): 0.7503903393709197
SG&A to revenue (%): 80.16079267077721
Free cash flow (dilution-adjusted): -3266921
Buyback yield (%): 0
Retained earnings: -227832212
Inventory turnover: 45.06087491304304
Receivables turnover: 1.0452737142575688
Capitalized R&D asset: 327512.14
Rosenberg metric: -4.48745786867723
FCF margin (%): -30.066793704319476
Revenue growth (%): -4.723278631542405
Rule of 40 score: -34.79007233586188
Financial ratios for RDZN — quarterly report dated 2025-09-30
Total revenue: 13679267
Gross profit: 7621688
Operating income: -3336176
Net income: -2108104
Capital expenditures: 81579
Operating cash flow: -6077507
Depreciation & amortization: 750207
Net tangible assets: -31876450
Owner earnings: -1439476
Buffett classification: The Gruesome
Stock price: 0.86
Shares outstanding: 84562603
Book value: -20850862
Market cap (USD): 72723838.58
Debt to equity: -1.1535010878686933
Current ratio: 0.5566578581339175
Quick ratio: 0.5531681388754073
COGS to revenue (%): 44.28292831772346
R&D to revenue (%): 1.0857964831010318
SG&A to revenue (%): 73.53557760075887
Free cash flow (dilution-adjusted): -6221462
Buyback yield (%): 0
Retained earnings: -229940316
Inventory turnover: 28.32299240210403
Receivables turnover: 0.9928509449827312
Capitalized R&D asset: 283735.19
Rosenberg metric: 15.0317168297888
FCF margin (%): -45.480960346778815
Revenue growth (%): 25.895820228069553
Rule of 40 score: -19.585140118709262
Financial ratios for RDZN — quarterly report dated 2025-12-31
Total revenue: 14355675
Gross profit: 9142650
Operating income: -2363493
Net income: -9148437
Capital expenditures: 469873
Operating cash flow: -7472110
Depreciation & amortization: 311600
Net tangible assets: -34701954
Owner earnings: -9306710
Buffett classification: The Gruesome
Stock price: 2.41
Shares outstanding: 84562603
Book value: -24088153
Market cap (USD): 203795873.23000002
Debt to equity: -1.2424588136749215
Current ratio: 0.5404816242167642
Quick ratio: 0.5376860924661012
Interest coverage ratio: -0.7415624470535082
COGS to revenue (%): 36.313339498142724
R&D to revenue (%): 2.04766407709843
SG&A to revenue (%): 75.9322497897173
Free cash flow (dilution-adjusted): -8188307
Buyback yield (%): 0
Retained earnings: -238986997
Inventory turnover: 29.507131940906774
Receivables turnover: 1.0880030697599616
Capitalized R&D asset: 420376.65
Rosenberg metric: 10.240168586605982
FCF margin (%): -57.03881566000902
Revenue growth (%): 4.944767873892658
Rule of 40 score: -52.09404778611636
Financial ratios for RGTI — annual report dated 2022-12-31
Total revenue: 13102000
Gross profit: 10229000
Operating income: -103703000
Net income: -71521000
Capital expenditures: 22737000
Operating cash flow: -62689000
Depreciation & amortization: 7017000
Net tangible assets: 150224000
Owner earnings: -87241000
Return on net tangible assets (%): -58.073942911918195
Buffett classification: The Gruesome
Stock price: 0.73
Shares outstanding: 332398807
Book value: 150224000
P/B ratio: 1.615262069376398
Market cap (USD): 242651129.10999998
Debt to equity: 0.26055091064011077
Current ratio: 7.101278043398308
Quick ratio: 7.101278043398308
Interest coverage ratio: -19.61842603102535
COGS to revenue (%): 21.927949931308195
R&D to revenue (%): 457.5789955731949
SG&A to revenue (%): 411.9981682185926
Free cash flow (dilution-adjusted): -130238000
Buyback yield (%): 0
Retained earnings: -278652000
Receivables turnover: 2.101363271852446
Capitalized R&D asset: 59952000
ROCI (R&D-adjusted, %): -26.375795598447286
FCF margin (%): -994.0314455808274
Rule of 40 score: -994.0314455808274
Financial ratios for RGTI — annual report dated 2023-12-31
Total revenue: 12008000
Gross profit: 9208000
Operating income: -71304000
Net income: -75107000
Capital expenditures: 9059000
Operating cash flow: -50579000
Depreciation & amortization: 7426000
Net tangible assets: 109588000
Owner earnings: -76740000
Return on net tangible assets (%): -70.02591524619484
Buffett classification: The Gruesome
Stock price: 0.99
Shares outstanding: 332398807
Book value: 109588000
P/B ratio: 3.0028362496806222
Market cap (USD): 329074818.93
Debt to equity: 0.27890827462860895
Current ratio: 3.706009913258984
Quick ratio: 3.706009913258984
Interest coverage ratio: -12.338466862779027
COGS to revenue (%): 23.317788141239173
R&D to revenue (%): 439.44037308461026
SG&A to revenue (%): 231.04596935376412
Free cash flow (dilution-adjusted): -72047000
Buyback yield (%): 0
Retained earnings: -353759000
Receivables turnover: 2.3877510439451184
Capitalized R&D asset: 92935840
ROCI (R&D-adjusted, %): -25.071548522907356
Rosenberg metric: -0.017030290899386177
FCF margin (%): -599.991672218521
Revenue growth (%): -8.349870248816975
Rule of 40 score: -608.341542467338
Financial ratios for RGTI — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 0.78
Shares outstanding: 332398807
Market cap (USD): 259271069.46
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for RGTI — annual report dated 2024-12-31
Total revenue: 10790000
Gross profit: 5697000
Operating income: -68510000
Net income: -200988000
Capital expenditures: 11098000
Operating cash flow: -50627000
Depreciation & amortization: 6906000
Net tangible assets: 126589000
Owner earnings: -205180000
Return on net tangible assets (%): -162.08359336119253
Buffett classification: The Gruesome
Stock price: 15.26
Shares outstanding: 332398807
Book value: 126589000
P/B ratio: 40.06987806855256
Market cap (USD): 5072405794.82
Debt to equity: 0.06951630868400888
Current ratio: 17.422937557933764
Quick ratio: 17.422937557933764
Interest coverage ratio: -21.047619047619047
COGS to revenue (%): 47.201112140871174
R&D to revenue (%): 461.07506950880446
SG&A to revenue (%): 226.66357738646897
Free cash flow (dilution-adjusted): -74794000
Buyback yield (%): 0
Retained earnings: -554747000
Receivables turnover: 4.445817882159044
Capitalized R&D asset: 104888720
ROCI (R&D-adjusted, %): -19.299889813730783
Rosenberg metric: -0.0665365372953305
FCF margin (%): -693.1788693234477
Revenue growth (%): -10.14323784143904
Rule of 40 score: -703.3221071648867
Financial ratios for RGTI — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 15.26
Shares outstanding: 332398807
Market cap (USD): 5072405794.82
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for RGTI — quarterly report dated 2025-03-31
Total revenue: 1472000
Gross profit: 442000
Operating income: -21632000
Net income: 42619000
Capital expenditures: 2547000
Operating cash flow: -13651000
Depreciation & amortization: 1829000
Net tangible assets: 207128000
Owner earnings: 41901000
Return on net tangible assets (%): 20.229519910393574
Buffett classification: The Gruesome
Stock price: 7.92
P/E ratio: 15.442634455524532
Shares outstanding: 332398807
Book value: 207128000
P/B ratio: 12.710008069599475
Market cap (USD): 2632598551.44
Debt to equity: 0.04059808427638948
Current ratio: 18.816801264044944
Quick ratio: 18.816801264044944
Effective tax rate (%): 0
COGS to revenue (%): 69.97282608695652
R&D to revenue (%): 1049.9320652173913
SG&A to revenue (%): 449.66032608695656
Free cash flow (dilution-adjusted): -20372000
Buyback yield (%): 0
Retained earnings: -512128000
Receivables turnover: 1.3782771535580525
Capitalized R&D asset: 15455000
ROCI (R&D-adjusted, %): -4.14664172776332
FCF margin (%): -1383.9673913043478
Rule of 40 score: -1383.9673913043478
Financial ratios for RGTI — quarterly report dated 2025-06-30
Total revenue: 1801000
Gross profit: 566000
Operating income: -19882000
Net income: -39654000
Capital expenditures: 5667000
Operating cash flow: -16169000
Depreciation & amortization: 1894000
Net tangible assets: 553263000
Owner earnings: -43427000
Return on net tangible assets (%): -7.849250718012953
Buffett classification: The Gruesome
Stock price: 11.86
P/E ratio: 1329.595228
Shares outstanding: 332398807
Book value: 553263000
P/B ratio: 7.125453628780525
Market cap (USD): 3942249851.02
Debt to equity: 0.014477743857803612
Current ratio: 41.570373921380636
Quick ratio: 41.570373921380636
COGS to revenue (%): 68.57301499167129
R&D to revenue (%): 750.8051082731816
SG&A to revenue (%): 384.56413103831204
Free cash flow (dilution-adjusted): -25390000
Buyback yield (%): 0
Retained earnings: -551782000
Receivables turnover: 1.0273816314888762
Capitalized R&D asset: 23876850
ROCI (R&D-adjusted, %): -2.4639427837385313
Rosenberg metric: 0.008023293432546102
FCF margin (%): -1409.7723486951693
Revenue growth (%): 22.35054347826087
Rule of 40 score: -1387.4218052169085
Financial ratios for RGTI — quarterly report dated 2025-09-30
Total revenue: 1947000
Gross profit: 404000
Operating income: -20549000
Net income: -200968000
Capital expenditures: 5889000
Operating cash flow: -13822000
Depreciation & amortization: 2074000
Net tangible assets: 371826000
Owner earnings: -204783000
Return on net tangible assets (%): -55.07495441416146
Buffett classification: The Gruesome
Stock price: 29.79
Shares outstanding: 332398807
Book value: 371826000
P/B ratio: 26.63116742920075
Market cap (USD): 9902160460.529999
Debt to equity: 0.020431599726753912
Current ratio: 39.2207323362558
Quick ratio: 39.2207323362558
COGS to revenue (%): 79.25012840267077
R&D to revenue (%): 771.4432460195172
SG&A to revenue (%): 304.7252182845403
Free cash flow (dilution-adjusted): -24010000
Buyback yield (%): 0
Retained earnings: -752750000
Receivables turnover: 0.855072463768116
Capitalized R&D asset: 29179890
ROCI (R&D-adjusted, %): -3.1173273587920654
Rosenberg metric: -0.01198047626090815
FCF margin (%): -1233.1792501284026
Revenue growth (%): 8.106607440310938
Rule of 40 score: -1225.0726426880917
Financial ratios for RGTI — annual report dated 2025-12-31
Total revenue: 7088000
Gross profit: 2064000
Operating income: -84660000
Net income: -216210000
Capital expenditures: 18676000
Operating cash flow: -58543000
Depreciation & amortization: 8169000
Net tangible assets: 546199000
Owner earnings: -226717000
Return on net tangible assets (%): -41.50813165165077
Buffett classification: The Gruesome
Stock price: 22.15
Shares outstanding: 332398807
Book value: 546199000
P/B ratio: 13.47976392313058
Market cap (USD): 7362633575.049999
Debt to equity: 0.0131215912149235
Current ratio: 37.42264647794602
Quick ratio: 37.42264647794602
COGS to revenue (%): 70.8803611738149
R&D to revenue (%): 865.476862302483
SG&A to revenue (%): 358.05586907449214
Free cash flow (dilution-adjusted): -94824000
Buyback yield (%): 0
Retained earnings: -770957000
Receivables turnover: 2.7785182281458254
Capitalized R&D asset: 112090940
ROCI (R&D-adjusted, %): -10.167603954605124
Rosenberg metric: -0.0730251256281407
FCF margin (%): -1337.8103837471783
Revenue growth (%): -34.30954587581094
Rule of 40 score: -1372.1199296229893
Financial ratios for RGTI — quarterly report dated 2025-12-31
Total revenue: 1868000
Gross profit: 652000
Operating income: -22597000
Net income: -18207000
Capital expenditures: 4573000
Operating cash flow: -14901000
Depreciation & amortization: 2372000
Net tangible assets: 546199000
Owner earnings: -20408000
Return on net tangible assets (%): -3.736367148237181
Buffett classification: The Gruesome
Stock price: 22.15
Shares outstanding: 332398807
Book value: 546199000
P/B ratio: 13.47976392313058
Market cap (USD): 7362633575.049999
Debt to equity: 0.0131215912149235
Current ratio: 37.42264647794602
Quick ratio: 37.42264647794602
COGS to revenue (%): 65.0963597430407
R&D to revenue (%): 928.6937901498928
SG&A to revenue (%): 315.89935760171306
Free cash flow (dilution-adjusted): -25052000
Buyback yield (%): 0
Retained earnings: -770957000
Receivables turnover: 0.7322618580948648
Capitalized R&D asset: 31873660
ROCI (R&D-adjusted, %): -2.993704880294109
Rosenberg metric: 0.01651131824234354
FCF margin (%): -1341.1134903640257
Revenue growth (%): -4.057524396507447
Rule of 40 score: -1345.1710147605331
Financial ratios for RPP.V — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 0.031496062992125984
Shares outstanding: 40039000
Market cap (USD): 1261070.8661417323
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for RPP.V — annual report dated 2022-12-31
Total revenue: 1127166.9117647058
Gross profit: 361172.0588235294
Operating income: 908491.9117647058
Net income: -88622.05882352941
Capital expenditures: 0
Operating cash flow: 989191.1764705882
Depreciation & amortization: 2477.941176470588
Net tangible assets: 2734516.176470588
Owner earnings: -86144.11764705883
Return on net tangible assets (%): -3.150250797135315
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 0.007352941176470588
Shares outstanding: 40039000
Book value: 2734516.176470589
P/B ratio: 0.10766234052588072
Market cap (USD): 294404.4117647059
Debt to equity: 4.5763512848546695
Current ratio: 0.0008022243093692566
Quick ratio: 0.0008022243093692566
Interest coverage ratio: 2.1146413638596364
COGS to revenue (%): 67.95753538772051
SG&A to revenue (%): 11.753831019598199
Free cash flow (dilution-adjusted): 989191.1764705882
Buyback yield (%): 0
Retained earnings: -742067.6470588235
Receivables turnover: 110.22052056370434
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 22.28430397723429
FCF margin (%): 87.75906799126128
Rule of 40 score: 87.75906799126128
Financial ratios for RPP.V — annual report dated 2023-12-31
Total revenue: 1073298.4848484849
Gross profit: 326178.78787878784
Operating income: 816082.5757575757
Net income: 265856.8181818182
Capital expenditures: 0
Operating cash flow: 926924.2424242424
Depreciation & amortization: 2042.4242424242423
Net tangible assets: 3095157.5757575757
Owner earnings: 267899.24242424243
Return on net tangible assets (%): 8.655431455979134
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 0.007575757575757576
P/E ratio: 1.1409365373819926
Shares outstanding: 40039000
Book value: 3095157.575757576
P/B ratio: 0.09800010182083056
Market cap (USD): 303325.75757575757
Debt to equity: 4.0687623482233235
Current ratio: 0.0013861635662458533
Quick ratio: 0.0013861635662458533
Effective tax rate (%): 25.803321112788442
Interest coverage ratio: 1.8875375412208737
COGS to revenue (%): 69.60968523822766
SG&A to revenue (%): 13.546035514987073
Free cash flow (dilution-adjusted): 915003.7878787878
Buyback yield (%): 0
Retained earnings: -498697.72727272724
Receivables turnover: 59.90249883725848
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 17.790323592848388
FCF margin (%): 85.25156802098317
Revenue growth (%): -4.779099382174365
Rule of 40 score: 80.4724686388088
Financial ratios for RPP.V — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 0.014814814814814814
Shares outstanding: 40039000
Market cap (USD): 593170.3703703703
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for RPP.V — annual report dated 2024-12-31
Total revenue: 1060946.8531468532
Gross profit: 235801.3986013986
Operating income: 768970.6293706294
Net income: 281358.04195804195
Capital expenditures: 30891.60839160839
Operating cash flow: 807202.7972027973
Depreciation & amortization: 4597.202797202797
Net tangible assets: 3146551.048951049
Owner earnings: 255063.63636363635
Return on net tangible assets (%): 8.106133744395018
Capex to operating income (%): 4.017267657789725
Buffett classification: The Great
Stock price: 0.027972027972027975
P/E ratio: 3.980593624329551
Shares outstanding: 40039000
Book value: 3146551.0489510484
P/B ratio: 0.3559363921158655
Market cap (USD): 1119972.0279720281
Debt to equity: 3.7188643443103877
Current ratio: 0.0012277487268884475
Quick ratio: 0.0012277487268884475
Effective tax rate (%): 25.35800485688154
Interest coverage ratio: 1.8563508677155784
COGS to revenue (%): 77.77443819150858
SG&A to revenue (%): 11.686288933094465
Free cash flow (dilution-adjusted): 768186.7132867132
Buyback yield (%): 0
Retained earnings: -178978.3216783217
Receivables turnover: 71.88940485216072
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 16.577639751552802
FCF margin (%): 72.4057676412546
Revenue growth (%): -1.1508105038809735
Rule of 40 score: 71.25495713737362
Financial ratios for RPP.V — quarterly report dated 2024-12-31
Total revenue: 274781.8181818182
Gross profit: 29120.979020979023
Operating income: 184868.53146853147
Net income: 133059.44055944055
Capital expenditures: 0
Operating cash flow: 100645.45454545454
Depreciation & amortization: 2467.1328671328674
Net tangible assets: 3146551.048951049
Owner earnings: 135526.57342657342
Return on net tangible assets (%): 4.307146819427999
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 0.027972027972027975
P/E ratio: 2.1042701353304434
Shares outstanding: 40039000
Book value: 3146551.0489510484
P/B ratio: 0.3559363921158655
Market cap (USD): 1119972.0279720281
Debt to equity: 3.7188643443103877
Current ratio: 0.0012277487268884475
Quick ratio: 0.0012277487268884475
Interest coverage ratio: 1.7011821182890494
COGS to revenue (%): 89.40214486763816
SG&A to revenue (%): 4.838931332678438
Free cash flow (dilution-adjusted): 100645.45454545454
Buyback yield (%): 0
Retained earnings: -178978.3216783217
Receivables turnover: 18.61912433661865
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 3.985436893203884
FCF margin (%): 36.627406868259115
Rule of 40 score: 36.627406868259115
Financial ratios for RPP.V — quarterly report dated 2025-03-31
Total revenue: 278016.78321678325
Gross profit: 93607.69230769231
Operating income: 272357.34265734267
Net income: 150806.2937062937
Capital expenditures: 0
Operating cash flow: 181241.25874125876
Depreciation & amortization: 6767.832167832168
Net tangible assets: 3297357.342657343
Owner earnings: 157574.1258741259
Return on net tangible assets (%): 4.778800399811589
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 0.027972027972027975
P/E ratio: 1.8566400652900725
Shares outstanding: 40039000
Book value: 3297357.3426573426
P/B ratio: 0.33965746250281803
Market cap (USD): 1119972.0279720281
Debt to equity: 3.5338118828364573
Current ratio: 0.011020602338959403
Quick ratio: 0.011020602338959403
Interest coverage ratio: 2.0575360557874163
COGS to revenue (%): 66.33020092362487
SG&A to revenue (%): 9.892998360012475
Free cash flow (dilution-adjusted): 181241.25874125876
Buyback yield (%): 0
Retained earnings: -28172.027972027972
Receivables turnover: 2.105741525423729
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 5.686660233472671
FCF margin (%): 65.19076173899046
Revenue growth (%): 1.1772849660760882
Rule of 40 score: 66.36804670506655
Financial ratios for RPP.V — quarterly report dated 2025-06-30
Total revenue: 286432.1167883212
Gross profit: 57382.48175182482
Operating income: 210439.41605839416
Net income: 75700
Capital expenditures: 0
Operating cash flow: 186995.62043795618
Depreciation & amortization: 0
Net tangible assets: 3517467.1532846713
Owner earnings: 75700
Return on net tangible assets (%): 2.152116756209366
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 0.0364963503649635
P/E ratio: 4.0640061969387435
Shares outstanding: 40039000
Book value: 3517467.153284671
P/B ratio: 0.4154345466732242
Market cap (USD): 1461277.3722627736
Debt to equity: 3.4439419124162423
Current ratio: 0.0011956084743770137
Quick ratio: 0.0011956084743770137
Interest coverage ratio: 1.5165408589989744
COGS to revenue (%): 79.96646381863958
SG&A to revenue (%): 13.458813695809505
Free cash flow (dilution-adjusted): 186995.62043795618
Buyback yield (%): 0
Retained earnings: 46294.1605839416
Receivables turnover: 19.467777943146302
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 4.146701604386987
FCF margin (%): 65.28444593947177
Revenue growth (%): 3.026915668244415
Rule of 40 score: 68.31136160771618
Financial ratios for RPP.V — quarterly report dated 2025-09-30
Total revenue: 323405.75539568346
Gross profit: 96405.75539568346
Operating income: 195161.87050359714
Net income: 7541.726618705036
Capital expenditures: 0
Operating cash flow: 191866.90647482016
Depreciation & amortization: 0
Net tangible assets: 3529629.496402878
Owner earnings: 7541.726618705036
Return on net tangible assets (%): 0.21366907281319394
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 0.07194244604316548
P/E ratio: 7.8464861220269455
Shares outstanding: 40039000
Book value: 3529629.4964028783
P/B ratio: 0.8160923405864231
Market cap (USD): 2880503.5971223027
Debt to equity: 3.6104252081811015
Current ratio: 0.007913518856651574
Quick ratio: 0.007913518856651574
Interest coverage ratio: 1.3136740257916426
COGS to revenue (%): 70.19046390261916
SG&A to revenue (%): 28.45858155334191
Free cash flow (dilution-adjusted): 191866.90647482016
Buyback yield (%): 0
Retained earnings: 53169.78417266187
Receivables turnover: 3.16025758193552
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 3.8460218856402704
FCF margin (%): 59.326991951665505
Revenue growth (%): 12.908342479864615
Rule of 40 score: 72.23533443153012
Financial ratios for RPP.V — quarterly report dated 2025-12-31
Total revenue: 344362.7737226277
Gross profit: 20464.963503649633
Operating income: 228502.9197080292
Net income: -480075.91240875906
Capital expenditures: 0
Operating cash flow: 189627.73722627736
Depreciation & amortization: 0
Net tangible assets: 3101081.02189781
Owner earnings: -480075.91240875906
Return on net tangible assets (%): -15.480921298694755
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 0.072992700729927
Shares outstanding: 40039000
Book value: 3101081.0218978096
P/B ratio: 0.9424309535572832
Market cap (USD): 2922554.744525547
Debt to equity: 4.127560650500732
Current ratio: 0.18406781566852762
Quick ratio: 0.18406781566852762
Interest coverage ratio: 1.4723749500270442
COGS to revenue (%): 94.05714988225368
SG&A to revenue (%): -10.471896679999237
Free cash flow (dilution-adjusted): 189627.73722627736
Buyback yield (%): 0
Retained earnings: -426129.92700729927
Receivables turnover: 8.564216602828253
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 4.92099270282281
FCF margin (%): 55.0662707168853
Revenue growth (%): 6.480100609620747
Rule of 40 score: 61.54637132650605
Financial ratios for RPP.V — annual report dated 2025-12-31
Total revenue: 1249114.598540146
Gross profit: 273367.8832116788
Operating income: 921238.6861313868
Net income: -239313.13868613137
Capital expenditures: 0
Operating cash flow: 760470.0729927006
Depreciation & amortization: 7064.233576642335
Net tangible assets: 3101081.02189781
Owner earnings: -232248.90510948905
Return on net tangible assets (%): -7.489288524533828
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 0.072992700729927
Shares outstanding: 40039000
Book value: 3101081.0218978096
P/B ratio: 0.9424309535572832
Market cap (USD): 2922554.744525547
Debt to equity: 4.127560650500732
Current ratio: 0.18406781566852762
Quick ratio: 0.18406781566852762
Interest coverage ratio: 1.5807768758383922
COGS to revenue (%): 78.11506778231822
SG&A to revenue (%): 9.97331248352848
Free cash flow (dilution-adjusted): 704432.1167883211
Buyback yield (%): 0
Retained earnings: -426129.92700729927
Receivables turnover: 31.065169640750085
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 19.839610180050276
FCF margin (%): 56.39451477163093
Revenue growth (%): 17.735831425973146
Rule of 40 score: 74.13034619760407
Financial ratios for SCILAL.NS — annual report dated 2024-03-31
Total revenue: 2064995.8028540593
Gross profit: -905384.3386497182
Operating income: -2782108.166446816
Net income: 5694927.449334453
Capital expenditures: 924571.2915217652
Operating cash flow: -45503057.92061398
Depreciation & amortization: 82743.73426070272
Net tangible assets: 386330495.263221
Owner earnings: 4853099.89207339
Return on net tangible assets (%): 1.2562041960386265
Buffett classification: The Gruesome
Stock price: 0.4698896353166987
P/E ratio: 38.43317213204505
Shares outstanding: 465799010
Book value: 386331694.4477755
P/B ratio: 0.5665445783645556
Market cap (USD): 218874126.93977928
Debt to equity: 2.7936255672611915e-05
Current ratio: 3.979216043755698
Quick ratio: 3.979216043755698
Effective tax rate (%): 13.811252268602543
Interest coverage ratio: -2320
COGS to revenue (%): 143.8443670150987
SG&A to revenue (%): 16.202090592334496
Free cash flow (dilution-adjusted): -46427629.21213575
Buyback yield (%): 0
Retained earnings: 295963544.7895431
Receivables turnover: 3.79295154185022
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -0.7196141379363825
FCF margin (%): -2248.315911730546
Revenue growth (%): 35.628924331454606
Rule of 40 score: -2212.6869873990913
Financial ratios for SCILAL.NS — quarterly report dated 2024-09-30
Capital expenditures: 0
Net tangible assets: 384106545.62828475
Buffett classification: The Gruesome
Stock price: 0.8342092689918778
Shares outstanding: 465799010
Book value: 384106545.62828475
P/B ratio: 1.0116303823816604
Market cap (USD): 388573851.62924033
Debt to equity: 2.798733728473073e-05
Current ratio: 3.7275
Quick ratio: 3.7275
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for SCILAL.NS — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 0.7266581186618487
Shares outstanding: 465799010
Market cap (USD): 338476632.28115165
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for SCILAL.NS — quarterly report dated 2025-03-31
Total revenue: 570493.3364507832
Gross profit: -31564.18050035071
Operating income: -432546.17722702824
Net income: -26229833.99579144
Capital expenditures: 0
Depreciation & amortization: 60790.273556231
Net tangible assets: 350888473.22889876
Owner earnings: -26169043.722235207
Return on net tangible assets (%): -7.457937697817757
Buffett classification: The Gruesome
Stock price: 0.5339012720270744
Shares outstanding: 465799010
Book value: 350889642.2726209
P/B ratio: 0.7087433027012342
Market cap (USD): 248690683.94795194
Debt to equity: 2.998490759650976e-05
Current ratio: 4.201545321749827
Quick ratio: 4.201545321749827
Effective tax rate (%): 1388.742102240092
COGS to revenue (%): 105.53278688524593
Buyback yield (%): 0
Retained earnings: 262792845.4524199
Receivables turnover: 2.8045977011494254
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -0.11412532194136425
Rule of 40 score: 0
Financial ratios for SCILAL.NS — annual report dated 2025-03-31
Total revenue: 2139350.011690437
Gross profit: 5845.2186111760575
Operating income: -2326397.007248071
Net income: -22139350.011690434
Capital expenditures: 747018.9385083001
Operating cash flow: -5777414.075286415
Depreciation & amortization: 270049.0998363339
Net tangible assets: 350888473.22889876
Owner earnings: -22616319.850362398
Return on net tangible assets (%): -6.445443944694318
Buffett classification: The Gruesome
Stock price: 0.5339012720270744
Shares outstanding: 465799010
Book value: 350889642.2726209
P/B ratio: 0.7087433027012342
Market cap (USD): 248690683.94795194
Debt to equity: 2.998490759650976e-05
Current ratio: 4.201545321749827
Quick ratio: 4.201545321749827
Effective tax rate (%): 390.7276634940129
Interest coverage ratio: -1990
COGS to revenue (%): 99.72677595628417
SG&A to revenue (%): 13.879781420765028
Free cash flow (dilution-adjusted): -6524433.0137947155
Buyback yield (%): 0
Retained earnings: 262792845.4524199
Receivables turnover: 10.517241379310343
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -0.613809163954905
FCF margin (%): -304.97267759562845
Revenue growth (%): 3.6006953977151728
Rule of 40 score: -301.37198219791327
Financial ratios for SCILAL.NS — quarterly report dated 2025-06-30
Total revenue: 668148.8415633045
Gross profit: 121694.35993447228
Operating income: -204774.16335127546
Net income: 1677978.0014041658
Capital expenditures: 0
Depreciation & amortization: 23402.761525860053
Owner earnings: 1701380.7629300258
Buffett classification: The Gruesome
Stock price: 0.621577346126843
P/E ratio: 43.13675629567643
Shares outstanding: 465799010
Market cap (USD): 289530112.4643108
Effective tax rate (%): 25.891472868217058
COGS to revenue (%): 81.78633975481611
Buyback yield (%): 0
Capitalized R&D asset: 0
Revenue growth (%): 17.117729318289093
Rule of 40 score: 17.117729318289093
Financial ratios for SCILAL.NS — quarterly report dated 2025-09-30
Total revenue: 691093.5738444193
Gross profit: -14656.144306651635
Operating income: -1754227.733934611
Net income: 472378.80496054114
Capital expenditures: 0
Depreciation & amortization: 77790.30439684329
Net tangible assets: 337588500.5636979
Owner earnings: 550169.1093573844
Return on net tangible assets (%): 0.16297033472370182
Buffett classification: The Gruesome
Stock price: 0.5507328072153326
P/E ratio: 135.7654035710024
Shares outstanding: 465799010
Book value: 337589627.95941377
P/B ratio: 0.7598894489917913
Market cap (USD): 256530796.37542278
Debt to equity: 3.005590398140541e-05
Current ratio: 3.6534637536600276
Quick ratio: 3.6534637536600276
Effective tax rate (%): 28.620102214650768
COGS to revenue (%): 102.12071778140294
Buyback yield (%): 0
Receivables turnover: 2.422924901185771
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -0.4809222828354634
Revenue growth (%): 3.434074992546532
Rule of 40 score: 3.434074992546532
Financial ratios for SCILAL.NS — quarterly report dated 2025-12-31
Total revenue: 629386.2092012923
Gross profit: 147042.44179570014
Operating income: -612676.8408154172
Net income: 1239835.1342319262
Capital expenditures: 0
Depreciation & amortization: 56811.85251197505
Owner earnings: 1296646.9867439012
Buffett classification: The Gruesome
Stock price: 0.5212208978500613
P/E ratio: 48.95493189106019
Shares outstanding: 465799010
Market cap (USD): 242784178.20986968
Effective tax rate (%): 27.727272727272727
Interest coverage ratio: -550
COGS to revenue (%): 76.63716814159291
Buyback yield (%): 0
Capitalized R&D asset: 0
Revenue growth (%): -8.928944932863576
Rule of 40 score: -8.928944932863576
Financial ratios for SES.TO — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 3.598425196850394
Shares outstanding: 218020431
Market cap (USD): 784530212.3385828
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for SES.TO — annual report dated 2022-12-31
Total revenue: 5883823529.411764
Gross profit: 362500000
Operating income: 258088235.29411763
Net income: 135294117.6470588
Capital expenditures: 29411764.70588235
Operating cash flow: 302205882.35294116
Depreciation & amortization: 130882352.94117646
Net tangible assets: 552941176.4705882
Owner earnings: 236764705.88235292
Return on net tangible assets (%): 42.81914893617021
Capex to operating income (%): 11.396011396011396
Buffett classification: The Great
Stock price: 4.573529411764706
P/E ratio: 7.3700384827173915
Shares outstanding: 218020431
Book value: 930882352.9411764
P/B ratio: 1.0711588316113745
Market cap (USD): 997122853.5441176
Debt to equity: 0.8143759873617693
Current ratio: 1.2549019607843135
Quick ratio: 1.0370370370370368
Effective tax rate (%): 26.984126984126984
Interest coverage ratio: 4.178571428571429
COGS to revenue (%): 93.83904023994002
SG&A to revenue (%): 1.4871282179455139
Free cash flow (dilution-adjusted): 217647058.82352942
Buyback yield (%): 0.44244946249114875
Retained earnings: -360294117.6470588
Inventory turnover: 75.08999999999999
Receivables turnover: 17.821826280623608
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 14.741705165896683
FCF margin (%): 3.6990752311922024
Rule of 40 score: 3.6990752311922024
Financial ratios for SES.TO — annual report dated 2023-12-31
Total revenue: 6245454545.454545
Gross profit: 387878787.8787879
Operating income: 268939393.93939394
Net income: 147727272.72727272
Capital expenditures: 153787878.78787878
Operating cash flow: 325757575.75757575
Depreciation & amortization: 153787878.78787878
Net tangible assets: 696212121.2121211
Owner earnings: 147727272.72727272
Return on net tangible assets (%): 21.218715995647443
Capex to operating income (%): 57.183098591549296
Buffett classification: The Good
Stock price: 6.696969696969696
P/E ratio: 9.883592872
Shares outstanding: 218020431
Book value: 898484848.4848485
P/B ratio: 1.6250426728836422
Market cap (USD): 1460076219.7272725
Debt to equity: 0.9291736930860033
Current ratio: 2.5211864406779663
Quick ratio: 2.2161016949152543
Effective tax rate (%): 24.124513618677042
Interest coverage ratio: 4.329268292682927
COGS to revenue (%): 93.78942261038331
SG&A to revenue (%): 1.6496846191169336
Free cash flow (dilution-adjusted): 152272727.27272728
Buyback yield (%): 8.457424812241253
Retained earnings: -312121212.1212121
Inventory turnover: 53.69444444444444
Receivables turnover: 23.092436974789916
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 14.966273187183809
FCF margin (%): 2.4381368267831154
Revenue growth (%): 6.146190725046014
Rule of 40 score: 8.58432755182913
Financial ratios for SES.TO — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 8.637037037037036
Shares outstanding: 218020431
Market cap (USD): 1883050537.3777776
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0